These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8115996)

  • 1. The difference between platelet and plasma FXIII used to study the mechanism of platelet microvesicle formation.
    Holme PA; Brosstad F; Solum NO
    Thromb Haemost; 1993 Oct; 70(4):681-6. PubMed ID: 8115996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulated Glanzmann's thrombasthenia platelets produced microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa.
    Holme PA; Solum NO; Brosstad F; Egberg N; Lindahl TL
    Thromb Haemost; 1995 Dec; 74(6):1533-40. PubMed ID: 8772233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet factor XIII becomes active without the release of activation peptide during platelet activation.
    Muszbek L; Polgár J; Boda Z
    Thromb Haemost; 1993 Mar; 69(3):282-5. PubMed ID: 8097064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular factor XIII crosslinks platelet cytoskeletal elements upon platelet activation.
    Serrano K; Devine DV
    Thromb Haemost; 2002 Aug; 88(2):315-20. PubMed ID: 12195706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombin-independent activation of platelet factor XIII by endogenous platelet acid protease.
    Lynch GW; Pfueller SL
    Thromb Haemost; 1988 Jun; 59(3):372-7. PubMed ID: 2903573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transformation of cellular factor XIII into an active zymogen transglutaminase in thrombin-stimulated platelets.
    Muszbek L; Haramura G; Polgár J
    Thromb Haemost; 1995 Apr; 73(4):702-5. PubMed ID: 7495082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor XIII improves platelet adhesion to fibrinogen by protein disulfide isomerase-mediated activity.
    Lahav J; Tvito A; Bagoly Z; Dardik R; Inbal A
    Thromb Res; 2013 Apr; 131(4):338-41. PubMed ID: 23276530
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of the crosslinking of fibrin and alpha 2-antiplasmin by platelets.
    Hevessy Z; Haramura G; Boda Z; Udvardy M; Muszbek L
    Thromb Haemost; 1996 Jan; 75(1):161-7. PubMed ID: 8713796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor XIII activation peptide is released into plasma upon cleavage by thrombin and shows a different structure compared to its bound form.
    Schroeder V; Vuissoz JM; Caflisch A; Kohler HP
    Thromb Haemost; 2007 Jun; 97(6):890-8. PubMed ID: 17549290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A coagulation factor becomes useful in the study of acute leukemias: studies with blood coagulation factor XIII.
    Kiss F; Simon A; Csáthy L; Hevessy Z; Katona E; Kiss C; Kappelmayer J
    Cytometry A; 2008 Mar; 73(3):194-201. PubMed ID: 18000871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleavage of factor XIII by human neutrophil elastase results in a novel active truncated form of factor XIII A subunit.
    Bagoly Z; Fazakas F; Komáromi I; Haramura G; Tóth E; Muszbek L
    Thromb Haemost; 2008 Apr; 99(4):668-74. PubMed ID: 18392324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Packaging zinc, fibrinogen, and factor XIII in platelet alpha-granules.
    Marx G; Korner G; Mou X; Gorodetsky R
    J Cell Physiol; 1993 Sep; 156(3):437-42. PubMed ID: 8360253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PhastSystem equipment used for crossed immunoelectrophoresis combined with immunoblotting of coprecipitated monoclonal antibodies as studied with platelet membrane receptor proteins.
    Solum NO; Aakhus AM; Pedersen T; Gaudernack G
    Electrophoresis; 1989 Nov; 10(11):752-8. PubMed ID: 2612475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of clotting factor XIII activity by nitric oxide.
    Catani MV; Bernassola F; Rossi A; Melino G
    Biochem Biophys Res Commun; 1998 Aug; 249(1):275-8. PubMed ID: 9705871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and assessment of enzyme immunoassay for platelet-derived microparticles.
    Osumi K; Ozeki Y; Saito S; Nagamura Y; Ito H; Kimura Y; Ogura H; Nomura S
    Thromb Haemost; 2001 Feb; 85(2):326-30. PubMed ID: 11246556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation.
    Fujimura H; Altar CA; Chen R; Nakamura T; Nakahashi T; Kambayashi J; Sun B; Tandon NN
    Thromb Haemost; 2002 Apr; 87(4):728-34. PubMed ID: 12008958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel aspects of platelet factor XIII function.
    Mitchell JL; Mutch NJ
    Thromb Res; 2016 May; 141 Suppl 2():S17-21. PubMed ID: 27207415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilinexin, a snake C-type lectin from Agkistrodon bilineatus venom agglutinates platelets via GPIb and alpha2beta1.
    Du XY; Navdaev A; Clemetson JM; Magnenat E; Wells TN; Clemetson KJ
    Thromb Haemost; 2001 Nov; 86(5):1277-83. PubMed ID: 11816718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex vivo microvesicle formation after prolonged ischemia in renal transplantation.
    Schuerholz T; Weissig A; Juettner B; Becker T; Scheinichen D
    Thromb Res; 2007; 120(2):231-6. PubMed ID: 17107705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.